These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3206379)

  • 1. [Characteristics of the aggregative function of thrombocytes in amyloidosis].
    Charyev BM; Kozlovskaia NL; Kozlovskaia LV; Mishchenko AL
    Ter Arkh; 1988; 60(6):85-8. PubMed ID: 3206379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Morphometric characteristics of thrombocytes in renal amyloidosis].
    Kozlovskaia NL; Kozlovskaia LV; Kuznetsov SL
    Ter Arkh; 1985; 57(6):98-101. PubMed ID: 4071422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lipiduria in the nephrotic syndrome].
    Neverov NI; Nikitina EA
    Ter Arkh; 1992; 64(6):16-8. PubMed ID: 1440328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical value of the study of hemostasis in nephrology].
    Mukhin NA; Poliantseva LR; Kozlovskaia LV; Kozlovskaia NL; Charyev BM
    Ter Arkh; 1988; 60(6):7-13. PubMed ID: 3206376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The chemotactic characteristics of the leukocytes and fibroblasts in amyloidosis].
    Karryeva BCh; Kozlovskiĭ LO; Liashko VN; Samoĭlov DV
    Ter Arkh; 1990; 62(6):58-62. PubMed ID: 2218930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [R proteins as a reflection of disorders in the cellular reception mechanisms in kidney diseases].
    Kozlovskaia LV; Zaĭtseva LI; Karryeva BCh; Kulagina NN; Artem'eva VB
    Ter Arkh; 1992; 64(4):79-81. PubMed ID: 1332207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of factors influencing platelet aggregation in patients with chronic glomerulonephritis (CGN)].
    Zdrojewski Z; Raszeja-Specht A; Kustosz J; Skibowska A; Rutkowski B
    Przegl Lek; 1996; 53(5):434-8. PubMed ID: 8754409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thrombocytic component of the hemostasis system in amyloidosis].
    Mukhin NA; Kozlovskaia LV; Kozlovskaia NL; Makatsariia AD; Mishchenko AL
    Vestn Akad Med Nauk SSSR; 1985; (11):8-13. PubMed ID: 4090658
    [No Abstract]   [Full Text] [Related]  

  • 9. Activation of platelets in patients with chronic proliferative glomerulonephritis and the nephrotic syndrome.
    Tomura S; Ida T; Kuriyama R; Chida Y; Takeuchi J; Motomiya T; Yamazaki H
    Clin Nephrol; 1982 Jan; 17(1):24-30. PubMed ID: 6459902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of a protein loading test on the fibrinolytic system in patients with chronic glomerulonephritis and amyloidosis].
    Poliantseva LR; Bumblite ID; Andreenko GV; Podorol'skaia LV; Zverev KV
    Ter Arkh; 1992; 64(6):19-21. PubMed ID: 1440329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Blood lipids in renal amyloidosis].
    Srinivas KV; Neverov NI; Kolonduk NV; Tambovtseva EV; Kozlova RI
    Urol Nefrol (Mosk); 1993; (1):28-31. PubMed ID: 7941122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The clinico-morphological characteristics of psoriatic nephropathy].
    Panasiuk NN; Mukhin NA; Varshavskiĭ VA; Maksimov NA; Nikolaev AIu; Poliantseva LR; Balkarov IM; Golov KG; Antonov MV; Aleksandrovskaia TN
    Ter Arkh; 1990; 62(6):99-103. PubMed ID: 2218939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in the thrombocyte and plasma factors of hemostasis in amyloidosis].
    Charyev BM; Kozlovskaia LV; Mishchenko AL; Kozlovskaia NL; Karryeva BCh
    Ter Arkh; 1990; 62(6):75-9. PubMed ID: 2218933
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative study of coagulation in the primary nephrotic syndrome and nephrotic syndrome secondary to renal amyloidosis].
    Ben Maïz H; Ayed K; Kheder A; Kastalli R; Kouki F; EL Matri A; Ben Ayed H
    J Urol Nephrol (Paris); 1979 Dec; 85(12):840-5. PubMed ID: 554868
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of platelet membrane structure in patients with chronic glomerulonephritis (CGN)].
    Zdrojewski Z; Nowak J; Raszeja-Specht A; Skibowska A; Kustosz J; Rutkowski B
    Przegl Lek; 1996; 53(5):431-3. PubMed ID: 8754408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered platelet shape change in hereditary gelsolin Asp187Asn-related amyloidosis.
    Kiuru S; Javela K; Somer H; Kekomäki R
    Thromb Haemost; 2000 Mar; 83(3):491-5. PubMed ID: 10744159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Laboratory findings and serum levels of amyloid A and soluble interleukin-2 receptors in patients with renal amyloidosis].
    Rysavá R; Merta M; Tesar V; Zabka J; Spicka I; Stejskalová A; Vernerová Z
    Cas Lek Cesk; 1998 Feb; 137(4):107-9. PubMed ID: 9531732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.
    Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
    Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Platelet aggregation and the fibronectin level of the blood in children with chronic glomerulonephritis].
    Pinelis VG; Razdol'kina TI; Sergeeva TV; Gozalishvili TV; Storozhevykh TP; Tsygin AN
    Urol Nefrol (Mosk); 1995; (4):17-9. PubMed ID: 7571193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Microcirculatory disorders in the genesis of sclerodermic nephropathy].
    Anikina NV; Guseva NG; Mach ES
    Ter Arkh; 1986; 58(8):62-5. PubMed ID: 3532413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.